CN112684093A - A kind of quality detection method of eleven prescription medicinal wine - Google Patents
A kind of quality detection method of eleven prescription medicinal wine Download PDFInfo
- Publication number
- CN112684093A CN112684093A CN202011445271.XA CN202011445271A CN112684093A CN 112684093 A CN112684093 A CN 112684093A CN 202011445271 A CN202011445271 A CN 202011445271A CN 112684093 A CN112684093 A CN 112684093A
- Authority
- CN
- China
- Prior art keywords
- solution
- medicinal liquor
- acetonitrile
- eleven
- party
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 27
- ZPFRAPVRYLGYEC-UHFFFAOYSA-N 1-(4-hydroxyphenyl)-3-(2,4,6-trimethoxyphenyl)propan-1-one Chemical compound COC1=CC(OC)=CC(OC)=C1CCC(=O)C1=CC=C(O)C=C1 ZPFRAPVRYLGYEC-UHFFFAOYSA-N 0.000 claims abstract description 60
- IAVUBSCVWHLRGE-UXEKTNMQSA-N (6e)-2,5-dihydroxy-6-[(e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-2,4-bis[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohex-4-ene-1,3-dione Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C(C(O)([C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C1=O)=O)=C(O)\C1=C(/O)\C=C\C1=CC=C(O)C=C1 IAVUBSCVWHLRGE-UXEKTNMQSA-N 0.000 claims abstract description 28
- ZZMASNSDVDSYKO-UHFFFAOYSA-N hydroxysafflor yellow A Natural products OCC1OC(C(O)C(O)C1O)C2=C(O)C(O)(C3OC(CO)C(O)C(O)C3O)C(=O)C(=C2O)C(=O)C=Cc4ccc(O)cc4 ZZMASNSDVDSYKO-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000004809 thin layer chromatography Methods 0.000 claims abstract description 24
- 239000009136 dragon's blood Substances 0.000 claims abstract description 19
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 16
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 14
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 14
- 238000004451 qualitative analysis Methods 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims description 107
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 101
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 60
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 53
- 239000012085 test solution Substances 0.000 claims description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000013558 reference substance Substances 0.000 claims description 27
- 239000012088 reference solution Substances 0.000 claims description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 16
- 238000010828 elution Methods 0.000 claims description 14
- 241000125175 Angelica Species 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 11
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 8
- 241001306121 Dracaena <Squamata> Species 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 241000244987 Daiswa polyphylla Species 0.000 claims description 4
- YEZWWUMWIFKEQM-UHFFFAOYSA-N O.OC.ClC(Cl)Cl.CCOC(C)=O Chemical compound O.OC.ClC(Cl)Cl.CCOC(C)=O YEZWWUMWIFKEQM-UHFFFAOYSA-N 0.000 claims description 4
- AZLPEJUVWWGLHA-UHFFFAOYSA-N ethyl acetate;hexane;methanol Chemical compound OC.CCCCCC.CCOC(C)=O AZLPEJUVWWGLHA-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 241000213006 Angelica dahurica Species 0.000 claims 1
- 238000004445 quantitative analysis Methods 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000003908 quality control method Methods 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 57
- 239000013642 negative control Substances 0.000 description 30
- 238000001704 evaporation Methods 0.000 description 24
- 238000002360 preparation method Methods 0.000 description 21
- 239000000523 sample Substances 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 16
- 238000001914 filtration Methods 0.000 description 16
- 238000005406 washing Methods 0.000 description 16
- 239000012982 microporous membrane Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000012488 sample solution Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 235000011114 ammonium hydroxide Nutrition 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 6
- 238000007605 air drying Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000382455 Angelica sinensis Species 0.000 description 5
- 244000020518 Carthamus tinctorius Species 0.000 description 5
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 5
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229940119485 safflower extract Drugs 0.000 description 4
- PPRSVUXPYPBULA-UHFFFAOYSA-N saponin A Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O PPRSVUXPYPBULA-UHFFFAOYSA-N 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- 241000123589 Dipsacus Species 0.000 description 2
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 2
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 2
- 244000107975 Strychnos nux-vomica Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- ONBIUAZBGHXJDM-UHFFFAOYSA-J bismuth;potassium;tetraiodide Chemical compound [K+].[I-].[I-].[I-].[I-].[Bi+3] ONBIUAZBGHXJDM-UHFFFAOYSA-J 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- -1 n-butyl alcohol saturated ammonia Chemical class 0.000 description 2
- 239000009286 sanguis draxonis Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000292342 Dracaena cochinchinensis Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
Images
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a quality detection method of eleven-prescription medicinal liquor, belonging to the technical field of quality detection of medicines. The invention firstly identifies three components of dragon's blood, angelica and rhizoma paridis in the medicinal liquor of the first ten prescription by using a thin-layer chromatography, and carries out qualitative analysis on the components; and then, the contents of the hydroxysafflor yellow A and the loureirin B in the medicinal liquor of the first ten are simultaneously detected by utilizing the high performance liquid chromatography, quantitative analysis is carried out, the operation condition is simple and easy to implement, and the detection result is accurate and feasible by adopting the conditions of the thin layer chromatography and the high performance liquid chromatography. The quality detection method of the invention has the advantages of stability, reliability, strong specificity and good reproducibility, and combines qualitative and quantitative analysis to ensure that the quality control and detection of the eleven-party medicinal liquor are safer and more effective.
Description
Technical Field
The invention belongs to the technical field of quality detection of medicines, and particularly relates to a quality detection method of eleven-prescription medicinal liquor.
Background
The ten-prescription medicinal liquor is a preparation which is independently researched and developed by Guangxi Chinese medicinal university and is worthy of being saved and has determined curative effect, and consists of multiple Chinese medicaments such as rhizoma paridis, pseudo-ginseng, safflower, calcined native copper, frankincense, large-leaved gentian, myrrh, teasel root, rhubarb, nux vomica and the like.
However, the previous quality control only involves the measurement of the components such as nux vomica, pseudo-ginseng, teasel root and the like, but no quality detection method suitable for the contents of the three components such as dragon's blood, angelica and rhizoma paridis, as well as the contents of hydroxysafflor yellow A and loureirin B exists, and an efficient and accurate detection method is urgently needed for further ensuring the stability and the curative effect of the medicinal liquor of the first ten prescriptions.
Disclosure of Invention
Aiming at the problems, the invention provides a quality detection method of eleven-party medicinal liquor, which is characterized in that three components of dragon's blood, angelica and rhizoma paridis in the eleven-party medicinal liquor are firstly identified by thin-layer chromatography for qualitative analysis; and simultaneously detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the tenth party by using a high performance liquid chromatography, and carrying out quantitative analysis, thereby ensuring the stability and effectiveness of the medicinal liquor of the tenth party.
The invention is realized by the following technical scheme:
a quality detection method of eleven-prescription medicinal liquor comprises the following steps:
carrying out qualitative analysis on three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using a thin-layer chromatography;
detecting the content of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by using a high performance liquid chromatography.
In the qualitative analysis of the components, the dracaena cochinchinensis, the angelica and the rhizoma paridis in the ten-party medicinal liquor are respectively extracted by n-butyl alcohol, ethyl ether and ethyl acetate.
As a further preferred aspect of the present invention, the thin layer chromatography further comprises a developing solvent, wherein the developing solvent used for the three components of the dragon's blood, the angelica and the rhizoma paridis is sequentially: the mixed solution of n-hexane-ethyl acetate-methanol with the volume ratio of 20-25:8-10:1, the mixed solution of toluene-acetone-ammonia water with the volume ratio of 1-3:1-4:0.2-0.5, and the lower layer solution of chloroform-ethyl acetate-methanol-water with the volume ratio of 8-10:15-20:8-15: 3.
As a further preferred aspect of the present invention, the high performance liquid chromatography comprises:
when the content of the hydroxysafflor yellow A is detected, octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285-one 403nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, the hydroxysafflor yellow A reference solution, the eleventh formula medicinal liquor test solution and the negative reference solution are respectively subjected to gradient elution to obtain a hydroxysafflor yellow A reference chromatogram and an eleventh formula medicinal liquor test chromatogram, and the content of the hydroxysafflor yellow A is determined by calculating the corresponding peak area in the eleven formula medicinal liquor test chromatogram;
when the content of the loureirin B is detected, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 255-280nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, gradient elution is respectively carried out on loureirin B reference substance solution, eleven-party medicinal liquor test solution and negative reference solution, a loureirin B reference substance chromatogram and an eleven-party medicinal liquor test solution chromatogram are obtained, and the content of the loureirin B is determined by calculating the corresponding peak appearance area in the eleven-party medicinal liquor test solution chromatogram.
As a further preferred aspect of the present invention, the gradient elution specifically comprises:
detecting hydroxy safflower yellow A content in 10-20% acetonitrile for 0-10 min; 10-15min, 20-26% acetonitrile; 15-20min, 26% acetonitrile; 20-30min, 26-35% acetonitrile; 30-40min, 35-20% acetonitrile.
Detecting the content of loureirin B with 20% acetonitrile for 0-10 min; 10-15min, 20-30% acetonitrile; 15-20min, 30% acetonitrile; 20-30min, 30-38% acetonitrile; 30-40min, 38-30% acetonitrile.
Compared with the prior art, the invention has the advantages and beneficial effects that:
1. the invention firstly identifies three components of dragon's blood, angelica and rhizoma paridis in the medicinal liquor of the first ten prescription by using a thin-layer chromatography for qualitative analysis; and then, the contents of the hydroxysafflor yellow A and the loureirin B in the medicinal liquor of the first ten are simultaneously detected by utilizing the high performance liquid chromatography, quantitative analysis is carried out, the operation condition is simple and easy to implement, and the detection result is accurate and feasible by adopting the conditions of the thin layer chromatography and the high performance liquid chromatography. The quality detection method of the invention has the advantages of stability, reliability, strong specificity and good reproducibility, and the qualitative and quantitative analysis of the invention is combined to lay a foundation for establishing the quality standard of the eleven-prescription medicinal liquor.
2. The method of the invention can effectively control the quality of the eleven medicinal liquor, is beneficial to stabilizing the quality of the product, ensures the safety and effectiveness of medication and better meets the requirements of medical treatment and market by identifying three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor and detecting the contents of hydroxy safflower yellow A and dracaolin B in the eleven medicinal liquor.
Drawings
FIG. 1 is a thin-layer chromatogram of sanguis Draxonis, in which: 1 represents a dragon blood reference substance, 2 represents a dragon blood reference medicinal material, 3 represents a dragon blood test sample, and 4 represents a negative reference substance.
FIG. 2 is a thin layer chromatogram of Angelica sinensis, in which: 1 represents angelica sinensis control medicinal materials, 2 represents eleven-party medicinal liquor, and 3 represents angelica sinensis negative control.
Fig. 3 is a thin layer chromatogram of rhizoma paridis, in which: 1 represents the paris polyphylla reference medicinal material, 2 represents the paris polyphylla sample, and 3 represents the paris polyphylla negative control.
FIG. 4 is a chromatogram of hydroxysafflor yellow A reference and an eleventh medicinal wine sample.
FIG. 5 is a chromatogram of a loureirin B reference substance and an eleven-ingredient medicinal liquor test sample.
Detailed Description
The present invention is further illustrated by the following examples, which are provided only for illustrating the present invention and are not intended to limit the scope of the present invention.
A quality detection method of eleven-prescription medicinal liquor comprises qualitatively analyzing three components of sanguis Draxonis, radix Angelicae sinensis, and rhizoma paridis in eleven-prescription medicinal liquor by thin layer chromatography; and detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by using a high performance liquid chromatography for quantitative analysis.
Example 1
The qualitative analysis of three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using the thin-layer chromatography comprises the following steps:
(1) identifying dragon's blood by thin-layer chromatography:
1) preparing a test solution: taking 50mL of a ten-party medicinal liquor, shaking and extracting with saturated n-butyl alcohol for 3 times, 50mL each time, combining n-butyl alcohol extracts, washing with an ammonia water test solution for 3 times, 50mL each time, discarding an alkali solution, combining n-butyl alcohol solutions, washing with water saturated n-butyl alcohol until the solution is neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of absolute ethyl alcohol into residues to dissolve and fix the volume to 5mL, and taking the residues as a test sample solution;
2) negative control solution preparation: taking 50mL of a sample prepared from a dragon blood medicinal material, shaking and extracting with water-saturated n-butyl alcohol for 3 times, 50mL each time, combining n-butyl alcohol extracts, washing with ammonia water for 3 times, 50mL each time, discarding an alkali solution, combining n-butyl alcohol solutions, washing with water-saturated n-butyl alcohol until the solution is neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of absolute ethyl alcohol into residues to dissolve and fix the volume to 5mL, and taking the residues as a negative control solution;
3) preparation of a reference solution: taking a loureirin B reference substance, adding absolute ethyl alcohol to prepare a solution containing 1mg of loureirin B per 1mL, and taking the solution as a reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), spreading with mixed solution of n-hexane-ethyl acetate-methanol at volume ratio of 20:8:1 as developing agent, spreading to span 8cm, taking out, air drying, fumigating in ammonia vapor for 15min, and inspecting in sunlight. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference. The results are shown in FIG. 1.
(2) Identification of angelica by thin-layer chromatography:
1) preparing a test solution: taking 30mL of eleven-prescription medicinal liquor, extracting with diethyl ether for 3 times, 20mL each time, discarding the diethyl ether layer, extracting the aqueous solution with water-saturated n-butanol for 3 times, 20mL each time, combining the extracts, washing with water-saturated n-butanol to neutrality, evaporating the n-butanol solution to dryness, adding 2mL of methanol into the residue to dissolve and fix the volume to 5mL to obtain a sample solution;
2) negative control solution preparation: extracting 30mL of a sample prepared from a Chinese angelica medicinal material with diethyl ether for 3 times, 20mL each time, discarding a diethyl ether layer, extracting an aqueous solution with water-saturated n-butyl alcohol for 3 times, 20mL each time, combining extract liquor, washing with water-saturated n-butyl alcohol to be neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve the residues and fixing the volume to 5mL to serve as a negative control solution;
3) preparation of a reference solution: taking ferulic acid reference substance, adding anhydrous alcohol to make into solution containing 1mg of loureirin B per 1mL as reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting, developing with toluene-acetone-ammonia water as developing agent at volume ratio of 1:1:0.2, spreading at a distance of 8cm, taking out, air drying, blowing off solvent with cold air until no ammonia smell is generated, and spray-developing with bismuth potassium iodide test solution. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference. The results are shown in FIG. 2.
(3) Identifying rhizoma paridis by thin-layer chromatography:
1) preparing a test solution: collecting 30mL of the eleven-prescription medicinal liquor, extracting with ethyl acetate for 3 times with shaking, 30mL each time, mixing the ethyl acetate extractive solutions, evaporating to dryness, adding 2mL of anhydrous ethanol into the residue to dissolve, and diluting to a constant volume of 5mL to obtain a sample solution;
2) negative control solution preparation: taking 30mL of a sample prepared from the rhizoma paridis medicinal material, extracting with ethyl acetate for 3 times with shaking, 30mL each time, combining ethyl acetate extracting solutions, evaporating to dryness, adding 2mL of absolute ethanol into residues to dissolve and fix the volume to 5mL, and taking the residue as a negative control solution;
3) preparation of a reference solution: taking a rhizoma paridis saponin A reference substance, and adding anhydrous ethanol to obtain a solution containing 1mg of rhizoma paridis saponin A per 1mL as a reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting with lower layer solution of chloroform-ethyl acetate-methanol-water at volume ratio of 8:15:8:3 as developing agent, spreading for 8cm, taking out, air drying, spraying 5% ethanol sulfate solution, and heating at 110 deg.C for 5min until spots are clear. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference. The results are shown in FIG. 3.
Example 2
The qualitative analysis of three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using the thin-layer chromatography comprises the following steps:
(1) identifying dragon's blood by thin-layer chromatography:
1) preparing a test solution: collecting 30mL of the eleven-prescription medicinal liquor, shaking and extracting with saturated n-butyl alcohol for 3 times, 30mL each time, combining n-butyl alcohol extracts, washing with ammonia water test solution for 2 times, 30mL each time, discarding alkali liquor, combining n-butyl alcohol solutions, washing with water saturated n-butyl alcohol until neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve and fix the volume to 5mL, and taking the residues as a test sample solution;
2) negative control solution preparation: taking 30mL of a sample prepared from a dragon blood medicinal material, shaking and extracting with water-saturated n-butyl alcohol for 3 times, 30mL each time, combining n-butyl alcohol extracts, washing with ammonia water for 3 times, 30mL each time, discarding an alkali solution, combining n-butyl alcohol solutions, washing with water-saturated n-butyl alcohol until the solution is neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve and fix the volume to 5mL, and taking the residues as a negative control solution;
3) preparation of a reference solution: adding methanol into loureirin B reference substance to obtain 1mg loureirin B solution per 1mL as reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), spreading with mixed solution of n-hexane-ethyl acetate-methanol at volume ratio of 25:10:1 as developing agent, spreading at a distance of 8cm, taking out, air drying, fumigating in ammonia vapor for 20min, and inspecting in sunlight. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference.
(2) Identification of angelica by thin-layer chromatography:
1) preparing a test solution: taking 30mL of eleven-prescription medicinal liquor, extracting with diethyl ether for 3 times, 20mL each time, discarding the diethyl ether layer, extracting the aqueous solution with water-saturated n-butanol for 3 times, 20mL each time, combining the extracts, washing with water-saturated n-butanol to neutrality, evaporating the n-butanol solution to dryness, adding 2mL of methanol into the residue to dissolve and fix the volume to 5mL to obtain a sample solution;
2) negative control solution preparation: extracting 30mL of a sample prepared from a Chinese angelica medicinal material with diethyl ether for 3 times, 20mL each time, discarding a diethyl ether layer, extracting an aqueous solution with water-saturated n-butyl alcohol for 3 times, 20mL each time, combining extract liquor, washing with water-saturated n-butyl alcohol to be neutral, evaporating the n-butyl alcohol solution to dryness, adding 2mL of methanol into residues to dissolve the residues and fixing the volume to 5mL to serve as a negative control solution;
3) preparation of a reference solution: taking ferulic acid reference substance, adding anhydrous alcohol to make into solution containing 1mg of loureirin B per 1mL as reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting, developing with toluene-acetone-ammonia water as developing agent at volume ratio of 3:4:0.5, spreading at a distance of 8cm, taking out, air drying, blowing off solvent with cold air until no ammonia smell is generated, and spray-developing with bismuth potassium iodide test solution. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference.
(3) Identifying rhizoma paridis by thin-layer chromatography:
1) preparing a test solution: collecting 30mL of the eleven-prescription medicinal liquor, extracting with ethyl acetate for 3 times with shaking, 30mL each time, mixing the ethyl acetate extractive solutions, evaporating to dryness, adding 2mL of anhydrous ethanol into the residue to dissolve, and diluting to a constant volume of 5mL to obtain a sample solution;
2) negative control solution preparation: taking 30mL of a sample prepared from the rhizoma paridis medicinal material, extracting with ethyl acetate for 3 times with shaking, 30mL each time, combining ethyl acetate extracting solutions, evaporating to dryness, adding 2mL of absolute ethanol into residues to dissolve and fix the volume to 5mL, and taking the residue as a negative control solution;
3) preparation of a reference solution: taking a rhizoma paridis saponin A reference substance, and adding anhydrous ethanol to obtain a solution containing 1mg of rhizoma paridis saponin A per 1mL as a reference substance solution;
4) thin layer chromatography and scanning conditions: respectively sucking 5 μ L of the above control solution, 10 μ L of the test solution and 10 μ L of the negative control solution, respectively dropping on the same silica gel G thin layer plate (10 × 10cm, Qingdao ocean chemical plant), applying round spotting with lower layer solution of chloroform-ethyl acetate-methanol-water at volume ratio of 10:20:15:3 as developing agent, spreading for 8cm, taking out, air drying, spraying 5% ethanol sulfate solution, and heating at 110 deg.C for 5min until spots are clear. In the chromatogram of the test solution, fluorescent spots with the same color appear at the corresponding positions of the chromatogram of the control solution, while the negative control solution has no interference.
Example 3
Simultaneously detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by utilizing a high performance liquid chromatography, and carrying out quantitative analysis, wherein the quantitative analysis comprises the following steps:
(1) detecting hydroxysafflor yellow A by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 403nm, the flow rate is 1.0mL/min, the column temperature is 30 ℃, and gradient elution is carried out;
TABLE 1 gradient elution Table
2) Preparation of a reference solution: taking a proper amount of a reference substance of the hydroxysafflor yellow A, precisely weighing, adding methanol to prepare a solution of the hydroxysafflor yellow A with the component mass concentration of 420 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a reference substance solution of the hydroxysafflor yellow A;
3) preparing a test solution: precisely measuring 5mL of a ten-party medicinal liquor, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer with water-saturated n-butyl alcohol for 2 times, each time with 10mL, mixing n-butyl alcohol, washing with water-saturated n-butyl alcohol for 2 times, each time with 30mL, evaporating the n-butyl alcohol layer to dryness in a water bath, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking uniformly, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer for 2 times by using water saturated n-butyl alcohol, extracting for 10mL each time, combining n-butyl alcohol, washing n-butyl alcohol saturated ammonia test solution for 2 times, evaporating to dryness in a water bath of the n-butyl alcohol layer, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. The results are shown in FIG. 4, and the content of hydroxysafflor yellow A is determined by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquors.
(2) Detecting loureirin B by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285nm, the flow rate is 1.0mL/min, the column temperature is 30 ℃, and gradient elution is carried out;
TABLE 2 gradient elution Table
2) Preparation of a reference solution: taking a proper amount of loureirin B reference substance, precisely weighing, adding methanol to prepare a loureirin B solution with the component mass concentration of 124 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a loureirin B reference substance solution;
3) preparing a test solution: precisely measuring 5mL of thirteen-party medicinal liquor, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, metering the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking the subsequent filtrate to obtain the medicinal liquor;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH value to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. The result is shown in figure 5, and the content of the loureirin B is determined by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquor.
Example 4
Simultaneously detecting the contents of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by utilizing a high performance liquid chromatography, and carrying out quantitative analysis, wherein the quantitative analysis comprises the following steps:
(1) detecting hydroxysafflor yellow A by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285nm, the flow rate is 1.0mL/min, the column temperature is 20 ℃, and gradient elution is carried out;
TABLE 1 gradient elution Table
2) Preparation of a reference solution: taking a proper amount of a reference substance of the hydroxysafflor yellow A, precisely weighing, adding methanol to prepare a solution of the hydroxysafflor yellow A with the component mass concentration of 420 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a reference substance solution of the hydroxysafflor yellow A;
3) preparing a test solution: precisely measuring 5mL of a ten-party medicinal liquor, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer with water-saturated n-butyl alcohol for 2 times, each time with 10mL, mixing n-butyl alcohol, washing with water-saturated n-butyl alcohol for 2 times, each time with 30mL, evaporating the n-butyl alcohol layer to dryness in a water bath, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking uniformly, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 30mL of hot water, dissolving for 3 times, transferring to a separating funnel, adding 10mL of diethyl ether, extracting for 1 time, standing, removing a diethyl ether layer, extracting a water layer for 2 times by using water saturated n-butyl alcohol, extracting for 10mL each time, combining n-butyl alcohol, washing n-butyl alcohol saturated ammonia test solution for 2 times, evaporating to dryness in a water bath of the n-butyl alcohol layer, adding a methanol solution into residues, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. And determining the content of hydroxysafflor yellow A by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquor.
(2) Detecting loureirin B by high performance liquid chromatography:
1) chromatographic conditions are as follows: octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 255nm, the flow rate is 1.0mL/min, the column temperature is 20 ℃, and gradient elution is carried out;
TABLE 2 gradient elution Table
2) Preparation of a reference solution: taking a proper amount of loureirin B reference substance, precisely weighing, adding methanol to prepare a loureirin B solution with the component mass concentration of 124 mu g/mL, filtering through a 0.45 mu m microporous membrane, and taking a subsequent filtrate to obtain a loureirin B reference substance solution;
3) preparing a test solution: precisely measuring 5mL of thirteen-party medicinal liquor, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, metering the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking the subsequent filtrate to obtain the medicinal liquor;
4) negative control solution preparation: taking 5mL of a sample prepared from safflower, evaporating to dryness in a water bath, adding 0.5% hydrochloric acid, dissolving for 3 times, 10mL each time, filtering, adding 2mL of concentrated ammonia water into the filtrate to adjust the pH value to 8, extracting for 3 times by using n-hexane, adding a methanol solution into the residue, fixing the volume to a 10mL measuring flask, shaking up, filtering through a 0.45-micrometer microporous membrane, and taking a subsequent filtrate to obtain the safflower extract;
5) and (3) determination: precisely sucking 10 μ L of the mixed reference solution, the sample solution, and the negative reference solution, respectively, injecting into a liquid chromatograph, and measuring. And determining the content of loureirin B by calculating the corresponding peak area in the chromatogram of the test sample of the eleven medicinal liquor.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and the like that are within the spirit and principle of the present invention are included in the present invention.
Claims (5)
1. A quality detection method of eleven-prescription medicinal liquor is characterized by comprising the following steps:
carrying out qualitative analysis on three components of dragon's blood, angelica and rhizoma paridis in the eleven medicinal liquor by using a thin-layer chromatography;
detecting the content of hydroxysafflor yellow A and dracaena B in the medicinal liquor of the first ten by using a high performance liquid chromatography.
2. The method for detecting the quality of the ten-party medicinal liquor according to claim 1, wherein in the qualitative analysis of the components, the dragon's blood, the angelica and the rhizoma paridis in the ten-party medicinal liquor are respectively extracted by n-butanol, diethyl ether and ethyl acetate.
3. The method for detecting the quality of the eleven-ingredient medicinal liquor according to claim 2, wherein a developing solvent is further used in the thin layer chromatography, and the developing solvents used for the three components of the dragon's blood, the Chinese angelica and the paris polyphylla are sequentially as follows: the mixed solution of n-hexane-ethyl acetate-methanol with the volume ratio of 20-25:8-10:1, the mixed solution of toluene-acetone-ammonia water with the volume ratio of 1-3:1-4:0.2-0.5, and the lower layer solution of chloroform-ethyl acetate-methanol-water with the volume ratio of 8-10:15-20:8-15: 3.
4. The quality detection method of the ten-party medicinal liquor according to any one of claims 1 to 3, characterized in that the high performance liquid chromatography is respectively as follows:
when the content of the hydroxysafflor yellow A is detected, octadecylsilane chemically bonded silica is used as a filling agent, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 285-one 403nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, the hydroxysafflor yellow A reference solution, the eleventh formula medicinal liquor test solution and the negative reference solution are respectively subjected to gradient elution to obtain a hydroxysafflor yellow A reference chromatogram and an eleventh formula medicinal liquor test chromatogram, and the content of the hydroxysafflor yellow A is determined by calculating the corresponding peak area in the eleven formula medicinal liquor test chromatogram;
when the content of the loureirin B is detected, acetonitrile-0.1% phosphoric acid solution is used as a mobile phase, the detection wavelength is 255-280nm, the flow rate is 1.0mL/min, the column temperature is 20-30 ℃, gradient elution is respectively carried out on loureirin B reference substance solution, eleven-party medicinal liquor test solution and negative reference solution, a loureirin B reference substance chromatogram and an eleven-party medicinal liquor test solution chromatogram are obtained, and the content of the loureirin B is determined by calculating the corresponding peak appearance area in the eleven-party medicinal liquor test solution chromatogram.
5. The quality detection method of the ten-party medicinal liquor according to claim 4, wherein the gradient elution is specifically as follows:
detecting hydroxy safflower yellow A content in 10-20% acetonitrile for 0-10 min; 10-15min, 20-26% acetonitrile; 15-20min, 26% acetonitrile; 20-30min, 26-35% acetonitrile; 30-40min, 35-20% acetonitrile.
Detecting the content of loureirin B with 20% acetonitrile for 0-10 min; 10-15min, 20-30% acetonitrile; 15-20min, 30% acetonitrile; 20-30min, 30-38% acetonitrile; 30-40min, 38-30% acetonitrile.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011445271.XA CN112684093B (en) | 2020-12-08 | 2020-12-08 | A quality detection method for eleven prescription medicinal wine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011445271.XA CN112684093B (en) | 2020-12-08 | 2020-12-08 | A quality detection method for eleven prescription medicinal wine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112684093A true CN112684093A (en) | 2021-04-20 |
CN112684093B CN112684093B (en) | 2022-11-25 |
Family
ID=75448799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011445271.XA Active CN112684093B (en) | 2020-12-08 | 2020-12-08 | A quality detection method for eleven prescription medicinal wine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112684093B (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607693A (en) * | 1991-03-14 | 1997-03-04 | Lvmh Recherche | Cosmetic or pharmaceutical composition, especially dermatological composition, containing oxyacanthine, intended in particular for stimulating hair growth or retarding hair loss |
JP2001270835A (en) * | 2000-03-15 | 2001-10-02 | Korea Yakult Co Ltd | Extract of perilla frutescens var. acuta kudo effective for prophylaxis and therapy of gastric ulcer, its use and process for obtaining berberine from the extract |
CN1384357A (en) * | 2002-05-30 | 2002-12-11 | 云南白药集团天然药物研究院 | Gongxuening capsule quality determining method |
CN1712953A (en) * | 2005-06-13 | 2005-12-28 | 昆明滇虹药业有限公司 | Quality control detection method of dragon's blood |
CN1850095A (en) * | 2006-02-22 | 2006-10-25 | 天津大学 | Use of chonglou saponin compound |
CN101057925A (en) * | 2007-06-01 | 2007-10-24 | 湖南金沙药业股份有限公司 | Preparation technology for 'jieguqili' capsule and its quality control method |
CN101648005A (en) * | 2008-08-13 | 2010-02-17 | 北京和润创新医药科技发展有限公司 | Medicinal composition for treating skin injury and ulcer and application thereof |
CN101780189A (en) * | 2009-01-20 | 2010-07-21 | 江苏康缘药业股份有限公司 | Method for controlling quality of Resina Draconis drug |
WO2012152044A1 (en) * | 2011-05-11 | 2012-11-15 | 西安千禾药业有限责任公司 | A method for detecting a haemostasis medicine |
CN104840967A (en) * | 2015-05-13 | 2015-08-19 | 上海中医药大学 | Taste correction method for oral liquid preparation of traditional Chinese medicine containing ethyl alcohol |
CN108553461A (en) * | 2018-01-06 | 2018-09-21 | 张恒源 | A kind of cold compress gel and preparation method thereof for treating newborn diapers dermatitis |
-
2020
- 2020-12-08 CN CN202011445271.XA patent/CN112684093B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607693A (en) * | 1991-03-14 | 1997-03-04 | Lvmh Recherche | Cosmetic or pharmaceutical composition, especially dermatological composition, containing oxyacanthine, intended in particular for stimulating hair growth or retarding hair loss |
JP2001270835A (en) * | 2000-03-15 | 2001-10-02 | Korea Yakult Co Ltd | Extract of perilla frutescens var. acuta kudo effective for prophylaxis and therapy of gastric ulcer, its use and process for obtaining berberine from the extract |
CN1384357A (en) * | 2002-05-30 | 2002-12-11 | 云南白药集团天然药物研究院 | Gongxuening capsule quality determining method |
CN1712953A (en) * | 2005-06-13 | 2005-12-28 | 昆明滇虹药业有限公司 | Quality control detection method of dragon's blood |
CN1850095A (en) * | 2006-02-22 | 2006-10-25 | 天津大学 | Use of chonglou saponin compound |
CN101057925A (en) * | 2007-06-01 | 2007-10-24 | 湖南金沙药业股份有限公司 | Preparation technology for 'jieguqili' capsule and its quality control method |
CN101648005A (en) * | 2008-08-13 | 2010-02-17 | 北京和润创新医药科技发展有限公司 | Medicinal composition for treating skin injury and ulcer and application thereof |
CN101780189A (en) * | 2009-01-20 | 2010-07-21 | 江苏康缘药业股份有限公司 | Method for controlling quality of Resina Draconis drug |
WO2012152044A1 (en) * | 2011-05-11 | 2012-11-15 | 西安千禾药业有限责任公司 | A method for detecting a haemostasis medicine |
CN104840967A (en) * | 2015-05-13 | 2015-08-19 | 上海中医药大学 | Taste correction method for oral liquid preparation of traditional Chinese medicine containing ethyl alcohol |
CN108553461A (en) * | 2018-01-06 | 2018-09-21 | 张恒源 | A kind of cold compress gel and preparation method thereof for treating newborn diapers dermatitis |
Non-Patent Citations (5)
Title |
---|
刘永忠 等: "重楼分散片的制备和质量分析", 《南昌大学学报(理科版)》 * |
刘玉珍 等: "保心宁胶囊质量标准的研究", 《中成药》 * |
姚苗苗 等: "RP-HPLC法同时测定红花中羟基红花黄色素A与红花黄色素A的含量", 《药物分析杂志》 * |
王常顺: "无敌药酒与无敌丹胶囊质量控制方法研究", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
郝永龙 等: "活血伸筋搽剂的薄层色谱鉴别", 《山东中医杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN112684093B (en) | 2022-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111044624B (en) | Quality detection method of Chinese medicinal preparation | |
CN102998411B (en) | A kind of detection method of ageratum dripping pill | |
CN103197027A (en) | Quality control method of astragalus-leech capsules capable of regulating collaterals | |
CN101028388B (en) | Quality inspection of Chinese-medicinal preparation for treating shortsighness and asthenopia | |
CN108037200B (en) | A kind of quality detection method of Zishen Ningshen pill | |
CN113484429B (en) | Method for establishing standard of peach pit qi-bearing soup material | |
CN106290644A (en) | A kind of quality determining method treating erysipelas medicine | |
CN102879516A (en) | Method for identifying Buyang Huanwu soup and measuring content of Buyang Huanwu soup | |
CN117665191B (en) | Method for detecting quality of effective components in known cellulitis particles | |
CN101385808B (en) | The detection method of Juper Anshendan | |
CN112684093A (en) | A kind of quality detection method of eleven prescription medicinal wine | |
CN114441685B (en) | Paris polyphylla standard decoction quality detection method | |
CN110716002A (en) | Quality control method of shiwei ginseng-angelica enema liquid | |
CN107576749A (en) | A kind of detection method of rheumatic cold pain piece | |
CN101987154B (en) | Thin-layer chromatographic detection method for cornel in gynecological recovery pills | |
CN101461860A (en) | Method for controlling quality of Chinese medicine liquid preparation | |
CN101112424B (en) | Asthma tablet detection method | |
CN105486763B (en) | A kind of quality determining method of female clever ball and its application | |
CN102809626A (en) | Quality control method of Qianshan Huoxue plaster | |
CN103076403A (en) | Quality inspection method for capsule for treating lower urinary tract infection | |
CN102078363A (en) | Detection method for humifuse euphorbia herb traditional Chinese medicine preparation | |
CN113567577A (en) | Thin-layer identification and high performance liquid chromatography detection method for index components in Shenshuai Yifang granules | |
CN113533613B (en) | Method for identifying specific components in liver soothing granules | |
CN113295816B (en) | Thin layer chromatography detection method for Yihechun preparation | |
CN114324726B (en) | Thin-layer chromatography detection method of kidney-nourishing and fetus-nourishing pill |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |